[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100115485":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":26,"responsibleParty":41,"collaborators":11,"id":45,"slug":11,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":11,"maxAge":11,"enrollmentInfo":53,"targetDuration":11,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"The Chaim Sheba Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"1","EXPERIMENTAL",null,[13],"Drug: methylphenidate, fluoxetin, risperidone",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DRUG","methylphenidate, fluoxetin, risperidone","first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Doron Gothelf, MD","CONTACT","972-03-5302663","gothelf@post.tau.ac.il",[27],{"facility":28,"status":29,"city":30,"state":11,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Schneider Children's Mediac Center of Israel","RECRUITING","Petah Tikva","49202","Israel",{"type":34,"coordinates":35},"Point",[36,37],34.88747,32.08707,{"lat":37,"lon":36},[40],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":11},{"type":42,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Prof. Doron Gothelf","Principal Investigator","100115485",false,"NCT00768820","The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome","The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors","VCFS","Inclusion Criteria:\n\n* chromosomal deletion proven by FISH examination\n\nExclusion Criteria:","ALL",{"count":54,"type":55},400,"ESTIMATED","INTERVENTIONAL",[58],"PHASE4","The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors",[61,62,63],"Velocardiofacial Syndrome","Williams Syndrome","Fragile X Syndrome",[65,66,67,68,69],"Velocardiofacial syndrome","Williams syndrome","fragile X syndrome","cognitive phenotype","psychiatric phenotype","2026-03-17",{"date":72,"type":73},"2026-03-18","ACTUAL",{"date":75,"type":11},"2001-05",{"date":77,"type":55},"2027-08",{"name":5,"class":6},1]